363 related articles for article (PubMed ID: 19773374)
1. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy.
Yeo SG; Kim JS; Cho MJ; Kim KH; Kim JS
Clin Cancer Res; 2009 Oct; 15(19):6201-7. PubMed ID: 19773374
[TBL] [Abstract][Full Text] [Related]
2. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer.
Fyles A; Milosevic M; Pintilie M; Syed A; Levin W; Manchul L; Hill RP
Radiother Oncol; 2006 Aug; 80(2):132-7. PubMed ID: 16920212
[TBL] [Abstract][Full Text] [Related]
3. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements.
Milosevic M; Fyles A; Hedley D; Pintilie M; Levin W; Manchul L; Hill R
Cancer Res; 2001 Sep; 61(17):6400-5. PubMed ID: 11522633
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Grecula JC; Lo SS; Jaroura D; Montebello J; Zhang H; Li K; Lu L; Huang Z; Fowler JM; Wu DH; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):502-8. PubMed ID: 19775824
[TBL] [Abstract][Full Text] [Related]
6. Transperineal high-dose-rate interstitial radiation therapy in the management of gynecologic malignancies.
Itami J; Hara R; Kozuka T; Yamashita H; Nakajima K; Shibata K; Abe Y; Fuse M; Ito M
Strahlenther Onkol; 2003 Nov; 179(11):737-41. PubMed ID: 14605742
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis and treatment for 98 patients with carcinoma of nasal cavity].
Hu WH; Xie FY; Chen DZ; Wu Y; Jiao JJ; Peng WJ; Yan C; Fang SH
Ai Zheng; 2004 Nov; 23(11 Suppl):1542-5. PubMed ID: 15566676
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
9. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
10. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy for cervical cancer in the elderly.
Ikushima H; Takegawa Y; Osaki K; Furutani S; Yamashita K; Kawanaka T; Kubo A; Kudoh T; Nishitani H
Gynecol Oncol; 2007 Nov; 107(2):339-43. PubMed ID: 17707075
[TBL] [Abstract][Full Text] [Related]
12. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
[TBL] [Abstract][Full Text] [Related]
14. Tumor regression dynamics with external radiotherapy in cancer cervix and its implications.
Datta NR; Rajkumar A; Basu R
Indian J Cancer; 2004; 41(1):18-24. PubMed ID: 15105575
[TBL] [Abstract][Full Text] [Related]
15. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
Gasinska A; Fowler JF; Lind BK; Urbanski K
Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
[TBL] [Abstract][Full Text] [Related]
16. Micronucleus assay in vivo provides significant prognostic information in human cervical carcinoma; the updated analysis.
Widel M; Kolosza Z; JedruĊ S; Lukaszczyk B; Raczek-Zwierzycka K; Swierniak A
Int J Radiat Biol; 2001 May; 77(5):631-6. PubMed ID: 11382342
[TBL] [Abstract][Full Text] [Related]
17. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix.
Huang EY; Wang CJ; Chen HC; Fang FM; Huang YJ; Wang CY; Hsu HC
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):834-42. PubMed ID: 18439764
[TBL] [Abstract][Full Text] [Related]
18. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
Lei X; Shan JL; Tang C; Zhao KW
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
[TBL] [Abstract][Full Text] [Related]
19. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma.
Nishio S; Katsumata N; Matsumoto K; Tanabe H; Yonemori K; Kohno T; Shimizu C; Ando M; Kasamatsu T; Fujiwara Y
Oncol Rep; 2008 Feb; 19(2):497-503. PubMed ID: 18202800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
